Proteomic analysis of mitochondrial proteins in hydroxycamptothecin-treated SMMC-7721 cells.
- Author:
Yu-rong FU
1
;
Zheng-jun YI
;
Yu-rong YAN
;
Zong-yin QIU
Author Information
- Publication Type:Journal Article
- MeSH: Antineoplastic Agents, Phytogenic; pharmacology; Camptothecin; analogs & derivatives; pharmacology; Cell Line, Tumor; Humans; Membrane Potentials; drug effects; Mitochondrial Proteins; metabolism; Proteomics
- From: Chinese Journal of Hepatology 2007;15(8):572-576
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the differentially expressed mitochondrial proteins in hydroxycamptothecin (HCPT)-treated SMMC-7721 cells by comparative proteomic analysis.
METHODSApoptosis of SMMC-7721 cells were induced by using HCPT and their mitochondria were isolated with a mitochondria isolation kit for cultured cells. Three different solubility protein fractions were extracted with ReadyPrep Sequential Extraction Kit and were separated by two-dimensional gel electrophoresis (2-DE). PDQuest software was used to differentiate mitochondrial proteins between control cells and HCPT-treated cells. Matrix assisted laser desorption/ionization time of flying mass spectrometry (MALDI-TOF-MS) was used to identify some of the different proteins.
RESULTSHighly purified mitochondria and high resolution 2-DE patterns of the proteins were obtained. Forty-four mitochondrial protein spots from the HCPT-treated cells showed different expressions compared to those of the control cells. Twenty of the different protein spots were analyzed by MALDI-TOF-MS.
CONCLUSIONDifferently expressed mitochondrial proteins in HCPT-treated cells and control cells were obtained in this study. This will be of help to understand the mechanism by which HCPT induces cell apoptosis.